The National Cancer Institute (NCI) has constructed a novel anti-SLAMF7 CAR T cell therapy that can specifically recognize SLAMF7- expressing target cells and eradicate SLAMF7-expressing tumors in mice.
| SparkCures ID | 342 |
|---|---|
| Generic Name | Anti-SLAMF7 CAR T Cells |
| Treatment Classifications | |
| Treatment Targets |
There are no resources, links or videos to display for this treatment.